MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss and
comprehensive loss
-$221,247K
(33.82%↑ Y/Y)
Product revenue, net
$175,110K
(216.93%↑ Y/Y)
Loss from operations
-$159,986K
(42.34%↑ Y/Y)
Total other expense
-$61,261K
(-7.74%↓ Y/Y)
Gross profit
$152,511K
(222.58%↑ Y/Y)
Interest income
$7,044K
(-53.53%↓ Y/Y)
Cost of revenue
$22,599K
(183.44%↑ Y/Y)
Total operating
expenses
$312,497K
(-3.77%↓ Y/Y)
Interest expense
$68,115K
(-5.41%↓ Y/Y)
Other expense, net
-$190K
(-2275.00%↓ Y/Y)
Selling, general and
administrative
$279,717K
(-3.77%↓ Y/Y)
Research and development
$32,780K
(-3.82%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT)